Yi Zhu

This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Mayo Foundation for Medical Education and Research, Unity Biotechnology, Inc., Buck Institute for Research on Aging. Active years: 2017-2024.

USPTO Granted Patents = 17 (Patent Applications = 7)

% Patents Active = 94.1

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 9.6

ph-index = 6

Forward Citations = 108(Granted Patents)

Location History:

Rochester, NY (US) (2019)
Rochester, MN (US) (2017 - 2024)

Company Filing History:

17 out of 1,802

Mayo Foundation for Medical Education and Research

patents

16 out of 41

Unity Biotechnology, Inc.

patents

15 out of 51

Buck Institute for Research on Aging

patents

4. 4 out of 3,790

Johns Hopkins University

patents

5. 1 out of 1

Buck Institute for Research Aging

patent

where one patent can have more than one assignee

Years Active: 2017-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11980616 - Treating liver disease by selectively eliminating senescent cells (2024-05-14),

2. 11517572 - Killing senescent cells and treating senescence-associated conditions using a SRC inhibitor and a flavonoid (2022-12-06),

3. 11351167 - Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue (2022-06-07),

4. 10517866 - Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor (2019-12-31),

5. 10478433 - Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss (2019-11-19),

6. 10478432 - Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye (2019-11-19),

7. 10413542 - Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase (2019-09-17),

8. 10328073 - Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells (2019-06-25),

9. 10328058 - Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques (2019-06-25),

10. 10258618 - Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen (2019-04-16),

11. 10213426 - Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population (2019-02-26),

12. 10130628 - Treatment of joint pain (2018-11-20),

13. 10010546 - Treatment of ophthalmic conditions by selectively removing senescent cells from the eye (2018-07-03),

14. 9993472 - Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 (2018-06-12),

15. 9980962 - Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease (2018-05-29),

Title: Inventor Yi Zhu - Revolutionizing Technology in Rochester

Introduction: Yi Zhu, a brilliant inventor based in Rochester, MN, is making waves in the tech industry with his groundbreaking innovations and patents.

Latest Patents: Zhu's most recent patents include a cutting-edge AI algorithm for autonomous vehicles and a revolutionary medical device for early disease detection.

Career Highlights: With a background in engineering and computer science, Zhu has worked for top tech companies, contributing to the development of state-of-the-art technologies.

Collaborations: Zhu has collaborated with leading research institutions and universities to further his research and bring his inventions to life, solidifying his reputation as a visionary in the field.

Conclusion: Yi Zhu's dedication to innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.